<?xml version="1.0" encoding="UTF-8"?>
<p id="Par6">Apart from its direct effects, the SARS-CoV-2 pandemic will bring chaos to fragile healthcare systems in LMIC. Currently, the day to day running of clinic services for chronic conditions including rheumatology outpatient clinics has stopped, jeopardizing new and existing patientsâ€™ access to consultations, procedures and medication for months to come. Communications with our RMD patients is suboptimal with inadequate telemedicine platforms operational to date. In addition, both HCQ and CQ are now in short supply for patients taking it for RMD indications, as it has been snatched up for prophylaxis and therapy of COVID illness. Even once clinical services resume, the catch-up will be calamitous. We have seen how the recent Ebola epidemic greatly undermined malaria control efforts, resulting in an estimated 1 million malaria cases seen in West Africa in 2014 [
 <xref ref-type="bibr" rid="CR22">22</xref>]. Similarly, the analysis of historic data shows that during the major influenza pandemics of 1889 and 1918, mortality due to TB significantly increased [
 <xref ref-type="bibr" rid="CR23">23</xref>]. In Latin America, COVID-19 infection is an additional challenge for the health systems and economies where recent Zika and Chikungunya outbreaks have had significant impact [
 <xref ref-type="bibr" rid="CR24">24</xref>]. The economic consequences of the COVID-19 pandemic are likely to hit LMIC hard, pushing many patients and their families below the breadline and shrinking healthcare resources.
</p>
